ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,389.06
0.08%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Immunotech Laborator (CE) (IMMB)

  7. Immunotech Laborator (CE) (IMMB) Noticias

IMMB

Immunotech Laborator (CE) (IMMB)

Immunotech Laborator (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:IMMB
FechaHoraFuenteTítuloSímboloCompañía
10/01/201408:00Access WireImmunotech Laboratories Inc. Corporate UpdateUSOTC:IMMBImmunotech Laborator (CE)
01/10/201312:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMMBImmunotech Laborator (CE)
24/09/201323:00OTC MarketsTier ChangeUSOTC:IMMBImmunotech Laborator (CE)
19/06/201308:05GlobeNewswire Inc.Immunotech Laboratories, Inc. Announces the Results From Gap Analysis ReportUSOTC:IMMBImmunotech Laborator (CE)
13/06/201311:36Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:IMMBImmunotech Laborator (CE)
13/06/201305:01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:IMMBImmunotech Laborator (CE)
30/05/201308:00GlobeNewswire Inc.Immunotech Laboratories ITV-1 Manufacturing AnnouncementUSOTC:IMMBImmunotech Laborator (CE)
28/05/201308:00GlobeNewswire Inc.Immunotech Laboratories Signs Funding Agreement With Curing Capital, Inc.USOTC:IMMBImmunotech Laborator (CE)
09/05/201308:00GlobeNewswire Inc.Immunotech Laboratories Corporate Shareholder Update SummaryUSOTC:IMMBImmunotech Laborator (CE)
29/04/201310:11GlobeNewswire Inc.Immunotech Laboratories, Inc. Provides Funding UpdateUSOTC:IMMBImmunotech Laborator (CE)
26/04/201308:00MarketwiredImmunotech Laboratories Begins Regulatory Process With US Food & Drug AdministrationUSOTC:IMMBImmunotech Laborator (CE)
15/04/201308:25MarketwiredImmunotech Laboraties Appoints New VP of Business DevelopmentUSOTC:IMMBImmunotech Laborator (CE)
08/04/201308:53MarketwiredImmunotech Laboraties Retains The Lebrecht Group to Upgrade the Company to Fully Reporting StatusUSOTC:IMMBImmunotech Laborator (CE)
05/04/201304:00MarketwiredMoneyTV with Donald Baillargeon, 4/5USOTC:IMMBImmunotech Laborator (CE)
28/03/201304:00MarketwiredMoneyTV with Donald Baillargeon, 3/28USOTC:IMMBImmunotech Laborator (CE)
25/03/201313:07Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:IMMBImmunotech Laborator (CE)
18/03/201308:00MarketwiredImmunotech Laboraties in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USAUSOTC:IMMBImmunotech Laborator (CE)
12/03/201309:45MarketwiredImmunotech Founder & Chief Scientific Officer Harry Zhabilov Comments on Recent HIV Baby Cure MedicineUSOTC:IMMBImmunotech Laborator (CE)
07/03/201308:12MarketwiredImmunotech Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV T...USOTC:IMMBImmunotech Laborator (CE)
01/03/201308:15MarketwiredImmunotech Relocates to New Research & Development Laboratory FacilityUSOTC:IMMBImmunotech Laborator (CE)
28/11/201212:31MarketwiredImmunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage PatientsUSOTC:IMMBImmunotech Laborator (CE)
11/10/201205:02Edgar (US Regulatory)Current report filing (8-K)USOTC:IMMBImmunotech Laborator (CE)
05/09/201214:31MarketwiredUpdate to Immunotech Laboratories, Inc. ShareholdersUSOTC:IMMBImmunotech Laborator (CE)
05/01/201107:49Edgar (US Regulatory)Annual Report (10-K)USOTC:IMMBImmunotech Laborator (CE)
 Showing the most relevant articles for your search:USOTC:IMMB

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
COIN
SOLUSD
Solana
NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
CCOM
US500
US 500
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
FX
USDMXN
US Dollar vs MXN
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados